Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis

By Palacios Santiago  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1553-1563

Informa Healthcare

Access to resources Recommend Favorite

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis – a clinical update on efficacy and safety

By Deal Chad L   Draper Michael W  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 199-210

Future Medicine

Access to resources Recommend Favorite

Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis?

By Simsa Peter   Mihalyi Attila   Kyama Cleophas M   Mwenda Jason M   Fülöp Vilmos   D’Hooghe Thomas M  

Women's Health, Vol. 3, Iss. 5, 2007-09 ,pp. : 617-628

Future Medicine

Access to resources Recommend Favorite

Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women

By Vogel Victor G  

Women's Health, Vol. 3, Iss. 2, 2007-03 ,pp. : 139-153

Future Medicine

Access to resources Recommend Favorite

Selective estrogen receptor modulators

By Petersen Nicole   Briggs Amber  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite